Luiz Miguel Camargo

Company: UbiquiTx, Inc.

Job title: Chief Scientific Officer

Seminars:

mRNA medicines for Protein Modulation – Targeted Protein Degradation 9:30 am

Leveraging AI/ML for programmable, modular therapeutic design Ubiquibodies (otherwise known as bio-protacs) for targeted protein degradation Design for compartment specificityRead more

day: Post-Conference Focus Day: Next Generation TPD